Achieve Life Sciences, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Achieve Life Sciences, Inc. (ACHV) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2021-03-11
- Achieve Life Sciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $0.00.
- Achieve Life Sciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Achieve Life Sciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2018 was $4.00K.
- Achieve Life Sciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2017 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2018-12-31 | $4.00K 10-K · filed 2021-03-11 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |